Op-T LLC
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus Type I Diabetes | Phase 2 | 2026-04-10 |
| Not Yet Recruiting | OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis Sepsis, Community Acquired Pneumonia (CAP) | Phase 1 | 2025-12-01 |
| Completed | OPT101 in Type 1 Diabetes Patients Diabetes Mellitus, Type 1 | Phase 1 | 2022-09-27 |
| Completed | 1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide. Healthy | Phase 1 | 2021-02-18 |